Natural Compounds Are Smart Players in Context to Anticancer Potential of Receptor Tyrosine Kinases: An In Silico and In Vitro Advancement-Reference-Cited by-同舟云学术

Natural Compounds Are Smart Players in Context to Anticancer Potential of Receptor Tyrosine Kinases: An In Silico and In Vitro Advancement

Published:2017 Issue: Volume: Page:177-202
ISSN:2451-991X
Container-title:Translational Bioinformatics and Its Application
language:
Short-container-title:

Author:

Singh Pushpendra,Kumar Shashank,Bast Felix

Publisher

Springer Netherlands

Link

http://link.springer.com/content/pdf/10.1007/978-94-024-1045-7_8

Reference178 articles.

1. Abolhasani H, Zarghi A, Hamzeh-Mivehroud M, Alizadeh AA, Mojarrad JS, Dastmalchi S. In-silico investigation of tubulin binding modes of a series of novel antiproliferative spiroisoxazoline compounds using docking studies. Iranian J Pharm Res: IJPR. 2015;14(1):141–8.

2. Abubakar IB, Lim K-H, Kam T-S, Loh H-S. Synergistic cytotoxic effects of combined δ-tocotrienol and jerantinine B on human brain and colon cancers. J Ethnopharmacol. 2016;184:107–18.

3. Alam S, Khan F. QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα. Drug Des Dev Ther. 2014;8:183–95.

4. Amin AR, Kucuk O, Khuri FR, Shin DM. Perspectives for cancer prevention with natural compounds. J Clin Oncol. 2009;27(16):2712–25.

5. Arora A, Scholar EM. Role of tyrosine kinase inhibitors in cancer therapy. J Pharmacol Exp Ther. 2005;315(3):971–9.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-silico Methods of Drug Design: Molecular Simulations and Free Energy Calculations;Phytochemistry: An in-silico and in-vitro Update;2019